Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence
Despite recent advances in cancer therapeutics, pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year overall survival of only 10%. Since either at or within a few months of diagnosis, most patients with PDAC will present with metastatic disease, a more individualized approa...
Main Authors: | Orimisan Samuel Adekolujo, Ahsan Wahab, Maxwell Oluwole Akanbi, Tolutope Oyasiji, Borys Hrinczenko, Olatunji Boladale Alese |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Cancer Biology & Therapy |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15384047.2023.2198479 |
Similar Items
-
Complete biochemical response after pulmonary metastasectomy in prostate adenocarcinoma
by: Jonathan Rush, et al.
Published: (2017-09-01) -
New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases
by: Konstantinos Grapatsas, et al.
Published: (2023-09-01) -
Lung Metastases: Current Surgical Indications and New Perspectives
by: Giuseppe Mangiameli, et al.
Published: (2022-04-01) -
Treatment patterns and outcomes for primary uterine leiomyosarcoma with synchronous isolated lung metastases: A National Cancer Database study of primary resection and metastasectomy
by: Alexandra C. Istl, et al.
Published: (2024-02-01) -
Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
by: Martijn van Dorp, et al.
Published: (2023-10-01)